J S Cacciola, A I Alterman, C P O'Brien, A T McLellan
{"title":"可卡因依赖药物临床疗效试验中的成瘾严重程度指数。","authors":"J S Cacciola, A I Alterman, C P O'Brien, A T McLellan","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>In sum, the ASI provides a standard and multidimensional initial evaluation of the subject. Furthermore, a profile of subjects is obtained that can be compared at different evaluation points, providing secondary outcomes. However, for the purposes of clinical trials evaluating pharmacotherapy for cocaine abusers, supplemental measures are needed at both baseline and followup to more specifically address cocaine use and problems.</p>","PeriodicalId":76229,"journal":{"name":"NIDA research monograph","volume":"175 ","pages":"182-91"},"PeriodicalIF":0.0000,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.\",\"authors\":\"J S Cacciola, A I Alterman, C P O'Brien, A T McLellan\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In sum, the ASI provides a standard and multidimensional initial evaluation of the subject. Furthermore, a profile of subjects is obtained that can be compared at different evaluation points, providing secondary outcomes. However, for the purposes of clinical trials evaluating pharmacotherapy for cocaine abusers, supplemental measures are needed at both baseline and followup to more specifically address cocaine use and problems.</p>\",\"PeriodicalId\":76229,\"journal\":{\"name\":\"NIDA research monograph\",\"volume\":\"175 \",\"pages\":\"182-91\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1997-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NIDA research monograph\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NIDA research monograph","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The Addiction Severity Index in clinical efficacy trials of medications for cocaine dependence.
In sum, the ASI provides a standard and multidimensional initial evaluation of the subject. Furthermore, a profile of subjects is obtained that can be compared at different evaluation points, providing secondary outcomes. However, for the purposes of clinical trials evaluating pharmacotherapy for cocaine abusers, supplemental measures are needed at both baseline and followup to more specifically address cocaine use and problems.